Posted On: 02/11/2014 7:02:20 AM
Post# of 63824
- The Mosaic Company Reports Fourth Quarter And Full Year 2013 Results
- Newpark Resources Announces Definitive Agreement to Sell Environmental Services Business
- Henry Schein Reports Record Fourth Quarter Results
- Microsemi Enables FPGA-Based Root-of-Trust Solution for Embedded Systems with Introduction of Secure Boot Reference Design
- Xilinx and Xylon Announce logiADAK Automotive Driver Assistance Kit Enabling Systems with up to Six Cameras
- Omnicom Reports Fourth Quarter 2013 Results
- Study by Independent Consulting Firm Shows 631%, 3-Year, Risk-Adjusted ROI Using RetailMeNot's Online Shopping Solutions to Increase In-Store Sales
- KonaRed Corp Analyst Report issued by BrokerBank Securities, Inc.
- Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
- Entergy Reports Fourth Quarter and Full Year Earnings
- American Capital Announces Proposed Refinancing of $450 Million Senior Secured Credit Facility
- USA Truck Reports Strong Revenue Growth and Improved Results from Underlying Operations for Fourth Quarter
- Ituran Location and Control Receives Notification Letter from the Nasdaq Stock Market
- Triple-S Management Corporation Reports Results for Fourth Quarter 2013
- Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
- CBIZ Reports 2013 Fourth-Quarter And Year-End Results
- Hundreds of flights canceled at Southern airports
- CYREN Schedules Fourth Quarter and Full Year Earnings Release for Monday, February 24, 2014
- NJ festival lets you eat, drink, floss with bacon
- Ahead of the Bell: US wholesale inventories
- Drone use highlights questions for journalists
- Huaneng Power International, Inc.: Adjustment of Tariffs of Gas Fired Power Plants
- Canadian Solar Announces the Concurrent Offerings of 2,600,000 Common Shares and US$100 Million Convertible Senior Notes
- Sino-Global Announces Fiscal 2014 Second Quarter Financial Results
- OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Prostate Cancer
More Stories
(0)
(0)
